Launch week offerEnds in00h00m00s

annual Promonthly Pro

Francisco Javier Barrero Hernández

Profesor

Universidad de Granada

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain

Articles (20)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Francisco Javier Barrero Hernández

Universidad de Granada

SPAIN

View details

Ana Maria Alonso Torres

Instituto de Investigación Biomédica de Málaga

SPAIN

View details

Eduardo Aguera-Morales

Profesor Asociado

Universidad de Córdoba

SPAIN

View details

LAURA NAVARRO CANTO

PROFESORA ASOCIADA

Universitat de Miguel Hernández d'Elx

SPAIN

View details

Luis Brieva Ruiz

Associated professor in Neurology

Hospital Universitari Arnau de Vilanova

SPAIN

View details

Laura Borrega

Head of Neurology Section

Hospital Universitario Fundacion Alcorcon

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francisco Javier Barrero Hernández

Research Interests

Make your next move.

Explore related searches

Articles (20)

Sexual Dysfunction in People with Multiple Sclerosis: Associated Factors and Effects on Quality of Life

Intrathecal synthesis of Epstein-Barr virus antibodies 15 years before onset of multiple sclerosis

Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.

Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration

Impact of fatigue on quality of life in adults with relapsing-remitting multiple sclerosis

Clinical Practice Evidence of Treatment Satisfaction with Moderate and High-Efficacy Drugs in Multiple Sclerosis

Case Report: Neurofilament light chain in the follow up of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with ocrelizumab

Impact of fatigue on quality of life in adults with relapsing-remitting multiple sclerosis,Impacto de la fatiga en la calidad de vida en los adultos con esclerosis múltiple remitente recurrente

Severe Neutropenia Secondary to Ocrelizumab: Risk Factors

The impact of oxidative stress on symptoms associated with multiple sclerosis

Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.

Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.

Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis

Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosis

Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis, (Front.Immunol, (2024), 15, (1480676), 10.3389/fimmu.2024.1480676)

Measles, Rubella, and Varicella-Zoster Viral Antibodies and Clinical Prognosis After 20 Years in Persons with Multiple Sclerosis

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.

Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach.

Enfermedades por priones humanas. Una revision general

Collaborators (6)

Francisco Javier Barrero Hernández

Ana Maria Alonso Torres

Eduardo Aguera-Morales

LAURA NAVARRO CANTO

Luis Brieva Ruiz

Laura Borrega

Make your next move.